CompletedNot Applicable

Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II

195 participantsStarted 2009-02

Plain-language summary

The purpose of this retrospective registry is to collect data about patients with acute HIT II (Heparin-induced Thrombocytopenia type II) which were treated with Lepirudin, Danaparoid, Argatroban or Fondaparinux. It is a main objective of this registry to mirror the daily routine in this indication in Germany.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Acute HIT II (Heparin-induced Thrombocytopenia type II), 4T-Score * Treatment of HIT with Lepirudin, Danaparoid, Argatroban or Fondaparinux Exclusion Criteria: \-

What they're measuring

Number of Participants Diagnosed With Thrombosis and/or Pulmonary Embolism After the Occurrence of HIT II

Timeframe: 19 January 2005 to 25 October 2009

Trial details

NCT IDNCT01304238

SponsorGlaxoSmithKline

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2010-01

Results submitted2011-01-27

View on ClinicalTrials.gov More Acute HIT II (Heparin-induced Thrombocytopenia Type II) trials